Aspirin during pregnancy: Indications and modalities from recent trials;Aspirine pendant la grossesse: Indications et modalités de prescription après la publication des derniers essais

Presse Medicale

Volumn 25, Issue 1, 1996, Pages 31-36

  Uzan, S ^a,b   Merviel, Ph ^a   Beaufils, M ^a   Breart G ^b   Salat Baroux, J ^a  

^a HÔPITAL TENON   (France)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID;

BLEEDING TIME; DRUG SAFETY; DRUG USE; FEMALE; HUMAN; INTRAUTERINE GROWTH RETARDATION; PREECLAMPSIA; PREGNANCY; PRESCRIPTION; REVIEW; RISK FACTOR;

ANGIOTENSIN II; ANTIPHOSPHOLIPID SYNDROME; ASPIRIN; CLINICAL TRIALS; CYCLOOXYGENASE INHIBITORS; FEMALE; FETAL GROWTH RETARDATION; HUMANS; INFANT, NEWBORN; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, SECOND; PREGNANCY, HIGH-RISK;

EID: 0030033724     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Vayne JR. Inhibition of prostaglandin synthesis as a mechanism of action of aspirin-like drugs. Nature 1971 ; 231-232-5.
2. Kelton JG. Antiplatelet agent: rationale and results. Clin Haematol 1983 ; 12:311-54.
3. Rees DD, Palmer RMJ, Moncada S. Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc Natl Acad Sci USA 1989 ; 86:3375-8.
4. Gant NF, Daley GL, Chand S, Whalley PJ, MacDonald PC. A study of angiotensin II pressor response thoughout primigravid pregnancy. J Clin Invest 1973 ; 522:2682-9.
5. Saxen I. Associations between oral clefts and drugs taken during pregnancy. Int J Epidemiol 1975 ; 4:37-44.
6. Slone D, Siskrnd V, Heinonen OP, Monson RR, Kaufman DW, Shapiro S. Aspirin and congenital malformations. Lancet 1976 ; i:1373-5.
7. Werler MM, Mitchell AA, Shapiro S. The relation of aspirin use during the first trimester of pregnancy to congenital cardiac defects. N Engl J Med 1989 ; 321:1639-42.
8. Di Sessa TG, Moretti ML, Khoury A, Pulliam DA, Arheart KL, Sibai BM. Cardiac function in fetuses and newborns exposed to low-dose aspirin during pregnancy. Am J Obstet Gynecol 1994 ; 4.892-900.
9. Nunez L, Larrea JL, Gil Aguado M, Reque JA, Matorras R, Minguez JA. Pregnancy in 20 patients with bioprosthetic valve replacement. Chest 1983 ; 84:26-8.
10. Benigni A, Gregorini G, Frusca T et al. Effect of low-dose aspirin on fetal and maternal generation of thromboxane by platelets in women at risk for pregnancy-induced hypertension. N Engl J Med 1989 ; 321:357-62.
11. Sibaï BM, Mirro R, Chesney CM, Leffler C. Low-dose aspirin in pregnancy. Obstet Gynecol 1989 ; 74:551-7.
12. Louden KA, Broughton Pipkin F, Heptinstall S et al. Neonatal platelet reactivity and serum thromboxane B2 production in whole blood: the effect of maternal low dose aspirin. Br J Obstet Gynaecol 1994 , 101:203-8.
13. CLASP. A randomised trial of low dose aspirin for the prevention and treatment of preeclampsia among 9364 pregnant women. Lancet 1994 ; 343:619-29.
14. Stuart MJ, Gross SJ, Elrad H, Graeber JE. Effects of acetylsalicylic-acid ingestion on maternal and neonatal hemostasis. N Engl J Med 1982 ; 307:909-12.
15. Rumack CMM, Guggenheim MA, Rumack BH, Peterson RG, Johnson ML, Braithwaite WR. Neonatal intracranial haemorrhage and maternal use of aspirin. Obstet Gynecol 1981 ; 58:552-6.
16. Mc Parland P, Pearce JM, Chamberlain JVP. Doppler ultrasound and aspirin in recognition and preventive of pregnancy-induced hypertension. Lancet 1990 ; 335:1552-5.
17. Sibaï BM, Caritis SN, Thom E et al. Prevention of preeclampsia with low-dose aspirin in healthy, nulliparous pregnant women. N Engl J Med 1993 ; 329:1213-18
18. Uzan S, Beaufils M, Bréart G, Bazin B, Capitant C, Paris J. Prevention of fetal growth retardation with low-dose aspirin: findings of the EPREDA trial. Lancet 1991 ; 337:1427-31.
19. Crandon AJ, Isherwood DM. Effect of aspirin on the incidence of pre-eclampsia. Lancet 1979 ; i:1356.
20. Hauth JC, Goldenberg RL, Parker RC et al. Low-dose aspinn therapy to prevent preeclampsia. Am J Obstet Gynecol 1993 ; 168:1083-93
21. Beaufils M, Uzan S, Sonsimoni R, Colau JC. Prevention of pre-eclampsia by antiplatelet therapy. Lancet 1985 ; i:840-2
22. Schiff E, Barkai G, Ben-Baruk G, Mashich S Low-dose aspirin does not influence the clinical course of women with mild pregnancy-induced hypertension. Obstet Gynecol 1990 ; 76:742-4.
23. Wallenburg HCS, Dekker GA, Makowitz JW, Rotmans N. Effect of low-dose aspirin on vascular refractoriness in angiotensin-sensitive primigravid women. Am J Obstet Gynecol 1991 ; 164:1169-73.
24. Bréart G. A meta-analysis of low-dose aspirin administration for the prevention of pregnancy-induced hypertensive disease in pregnant women at high risk. Unpublished data.
25. Wallenburg HCS, Rotmans N. Prevention of recurrent idiopathic fetal growth retardation by low-dose aspirin and dipyridamole. Am J Obstet Gynecol 1987 , 157:1230-5.
26. Tradinger BJ, Cook CM, Thompson R, Gilles WB, Connelly A. Low-dose aspirin therapy improves fetal weight in umbilical placental insufficiency. Am J Obstet Gynecol 1988 ; 159:681-5.
27. Hamid R, Robson M, Pearce JM. Low dose aspirin in women with raised maternal serum alpha-fetoprotein and abnormal doppler waveform patterns from the uteroplacental circulation. Br J Obstet Gynaecol 1994 ; 101:481-4.
28. Branch DW, Scott JR, Kochenour NK, Hershgold E. Obstetrics complications associated with the lupus anticoagulant. N Engl J Med 1985 ; 313:1322-6.
29. Krause P, Blank M, Gilbrut B, Shoenfeld Y. The effect of aspirin on recurrent fetal loss in experimental antiphospholipid syndrom. Am Reprod Immunol 1993 ; 29:155-61.
30. Ivy AD, Nelson D, Buches G. The standardization of certain factors in the cutaneous venostasis. Bleeding time technique. J Lab Clin Med 1941 ; 26:1812.